Products
-
- BBB DamageCell Death and ApoptosisNeuroinflammationNeuronal Damage and RepairOxidative StressVascular Mechanisms
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Recombinant Human DLK-1 Protein (6×His Tag) (AC1161)
Cat.#: ACPP-1161
Specifications
Despition Recombinant Human DLK-1 Protein (6×His Tag) for SDS-PAGE SIZE 50 µg Source Recombinant Protein Length Fragment Expression System HEK293 cells Protein Species Human Sequence DLK1 (Ala24-Gln303) + 6×His Tag Molecular Weight 30.6 kDa without signal peptide Purity > 85% by SDS-PAGE and Coomassie blue staining. Form Lyophilized Tag C-terminal 6×His Tag Applications SDS-PAGE Storage Lyophilized was stored at -20°C to -80°C, while reconstituted was aliquot and stored at -80°C. Avoid freeze/thaw cycles. Shipping Shipped at 4°C Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Size Price ACPP-1005 Recombinant Human CNTF Protein (AC1005) 50 µg inquiry ACPP-1302 Noelin Blocking Peptide (AC1302) 250 µg inquiry ACPP-1106 Recombinant Human c-Kit Protein (6×His Tag) (AC1106) 50 µg inquiry ACPP-1581 Rat FGF 9 Protein (AC1581) 2 µg inquiry ACPP-1150 Synthetic Nanodisc Human TRPV1 Protein (AC1150) 10 µg inquiry ACPP-1119 CD56 Blocking Peptide (AC1119) 250 µg inquiry ACPP-1148 Recombinant Human NCAM1 Protein (Fc Tag) (AC1148) 50 µg inquiry ACPP-1712 Human NME2 Protein (AC1712) 5 µg inquiry ACPP-1828 Human EPHA2 Protein (AC1828) 2 µg inquiry ACPP-1269 Mouse GDNF Protein (AC1269) 2 µg inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
0Inquiry Basket